Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel t-BuOK promoted room temperature synthesis of N-dithiocarbamate indoles. High yield, simple operation, ideal for reliable pharmaceutical intermediate supplier.
Patent CN115745825B details nickel-catalyzed amide alkylation. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.
Patent CN102786533A discloses a novel reductive coupling method for [5] and [7] helicene analogs using solid phosgene, offering a scalable route for high-purity electronic chemical intermediates.
Patent CN120136946B reveals a one-pot dienogest method reducing waste and cost. Enhances supply chain reliability for high-purity API manufacturing globally.
Patent CN104402803A details high-yield L-high proline synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for global buyers.
Patent CN117603169B reveals a novel route for pilocarpine intermediates. Achieve higher yields and safer scale-up for pharmaceutical manufacturing supply chains.
Patent CN112300184B details a high-yield route for racemic camptothecin intermediates. Discover cost-effective manufacturing and supply chain advantages for API production.
Advanced catalytic method for high-purity 1-amino-2,3-propanediol synthesis. Reduces by-products and enhances supply chain reliability for iohexol intermediates.
Patent CN117105817B details safe synthesis avoiding toxic cyanide. Reliable supplier for pharmaceutical intermediates ensuring cost reduction and supply continuity.
Patent CN114230468A reveals a green SBA-15 catalytic route for nitrobenzaldehyde. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel nucleophilic substitution route for Montelukast intermediate. High optical purity, mild conditions, cost-effective manufacturing for global supply chains.
Patent CN104693071A reveals high-yield Vorinostat synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN110563696B reveals a robust method for heteroatom-containing cyclohexene halides, offering significant cost reduction and simplified purification for fine chemical manufacturing.
Novel catalytic route for high-purity fluoroquinolone intermediates. Reduces alkali usage and boosts yield to 82.5% via one-pot synthesis.
Patent CN100408555C reveals a high-yield synthesis of 4-chloro-3-hydroxybutyronitrile using basic catalysts, offering significant cost reduction and waste minimization for supply chains.
Patent CN1259941A details a streamlined route for 3-N,N-dicyclobutylamino-8-fluoro-benzopyran derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN115232071B details zinc-catalyzed quinoline synthesis replacing gold catalysts. Offers scalable cost reduction and high purity for pharmaceutical intermediates manufacturing supply chains.
Advanced esterification process for Metronidazole Benzoate yielding 91.5-95%. Offers significant cost reduction in pharma manufacturing through efficient solvent recycling.
Novel palladium-free synthesis of 3-methylbenzo[d]oxazol-2(3H)-one-5-boronic acid pinacol ester. High purity >99%, total yield >81%, cost-effective API intermediate manufacturing.
Patent CN112374976B details a 3-step route to (1E,4E)-1,5-bis(2-methoxyphenyl)pent-1,4-dien-3-one avoiding heavy metals and column chromatography for cost-effective manufacturing.